Scientists Push Back on Fish Oil–Cognitive Decline Scare Study
This letter to the editor responds to an earlier study that had linked omega-3 supplement use to faster cognitive decline, based on brain scans (FDG-PET) from an Alzheimer’s research database. The authors argue that the original finding was likely misleading due to several methodological problems.
They point out that the original study lumped all supplement users together without distinguishing high-quality pharmacy-grade fish oil from potentially oxidized over-the-counter products. They also note that people who start taking supplements may already differ in subtle ways (worry about their health, lifestyle habits) that statistical matching can’t fully account for, and that the brain-scan changes used as evidence reflect general metabolic activity rather than a specific marker of nerve cell damage.
The authors suggest that any real effect likely depends on a person’s existing omega-3 levels and oxidative stress, and they call for better-designed studies using blood-based omega-3 measurements and more precise brain imaging methods before drawing firm conclusions.
What this means for you
This commentary suggests that an earlier headline-grabbing claim linking fish oil supplements to worsened brain aging was based on limited, hard-to-interpret data, and it should be treated as a starting point for further research rather than a firm warning.
Ready to start? The ALP Protocol delivers the EPA & DHA doses used in the research.
Start the ALP ProtocolSource
The journal of prevention of Alzheimer's disease · 2026-08-18 · DOI: 10.1016/j.tjpad.2026.100660
Read the original source ↗This summary is for educational purposes only and is not medical advice. Always talk to your healthcare provider before making changes to your supplement routine.